期刊文献+

PKA磷酸化p21^(WAF)后对其泛素化修饰和稳定性的影响

Phosphorylation of p21^(WAF) by PKA affects its ubiquitination and stability
原文传递
导出
摘要 目的:探索p21被蛋白激酶A(PKA)磷酸化修饰后对其泛素化修饰和稳定性的影响。方法:构建p21可能磷酸化位点的突变体p21 T145A,观察PKA体外磷酸化修饰p21;W estern印迹分析PKA特异性抑制剂H89对p21稳定性的影响;通过免疫沉淀分析H89对p21泛素化修饰的影响以及p21 Thr 145突变前后和Skp2结合能力的变化。结果:PKA体外磷酸化修饰p21的Thr 145;PKA特异性抑制剂H89能够提高p21的稳定性并抑制p21的泛素化修饰;野生型(w ild)p21比p21 T145A结合Skp2的能力强。结论:PKA磷酸化修饰p21的Thr145后导致其结合E3连接酶结合亚基Skp2的能力增强,从而促进p21的泛素化修饰,导致p21稳定性的降低。 Objective:To investigate whether the phosphorylation of p21 by PKA affects its ubiquitination and stability. Methods: Site-directed mutagenesis was used to engineer p21 construct defective in potential acceptor site for PKA-dependent phosphorylation. Western blotting was used to analyze the stability of p21 after PKA specific inhibitor H89 treatment and the immunoprecipitation analysis was used to investigate whether H89 inhibits the ubiquitination of p21 and whether p21 phosphorylation at Thr 145 affects its Skp2 binding ability. Results: It was confirmed that PKA specifically phosphorylated p21 at Thr 145 by in vitro kinase analysis. PKA specific inhibitor H89 treatment significantly inhibited the ubiquitination and increased protein stability of p21 in HeLa cells. The p21 T145A construct displayed decrease in Skp2 binding compared withwild p21. Conclusion: PKA phosphorylates p21 at Thr 145 in vitro. The phosphorylation of p21 might increase p21 binding to Skp2 and accelerate the ubiquitination of p21 and its degradation.
出处 《军事医学科学院院刊》 CSCD 北大核心 2005年第5期410-413,共4页 Bulletin of the Academy of Military Medical Sciences
基金 国家自然科学基金资助项目(No.30100223 30300416)
关键词 蛋白激酶A p21^WAF 泛素化修饰 SKP2 细胞周期蛋白质类 protein kinase A p21^WAF ubiquitination Skp2 cell cycle proteins
  • 相关文献

参考文献9

  • 1Dotto GP. p21WAFl/Cipl : more than a break to cell cycle [J] ?Biochim Biophys Acta, 2000, 1471 ( 1 ) : M43 - M56.
  • 2钱俊杰,孙国敬,孟祥兵,宋宜,梅柱中,刘斌,董燕,孙志贤.HeLa细胞中Skp2的表达调控p21WAFCIP1稳定性[J].中国生物化学与分子生物学报,2004,20(6):732-737. 被引量:5
  • 3Kornitzer D, Ciechanover A. Modes of regulation of ubiquitin-mediated protein degradation [ J ]. J Cell Physiol, 2000, 182 ( 1 ) :1 -11.
  • 4Rossig L, Jadidi AS, Urbich C, et al. Akt-dependent phosphorylation of p21 ( Cipl ) regulates PCNA binding and proliferation of endothelial cells[J]. Mol Cell Biol, 2001,21 (16) :5644 -5657.
  • 5Rossig L, Badorff C, Holzmann Y, et al. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cipl degradation [J]. J Biol Chem, 2002, 277(12) :9684 -9689.
  • 6Matyakhina L, Lenherr SM, Stratakis CA. Protein kinase A and chromosomal stability [ J]. Ann N Y Acad Sci, 2002, 968:148 -157.
  • 7Scott MT, Mortice N, Ball KL. Reversible phosphorylation at the C-terminal regulatory domain of p21 ( Wafl/Cipl ) modulates proliferating cell nuclear antigen binding [ J ]. J Biol Chem, 2000,275 ( 15 ) : 11529 - 11537.
  • 8Carrano AC, Eytan E, Hershko A, et al. Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [ J ]. Nat Cell Biol, 1997, 1(4) :193 -199.
  • 9Cohen P. The regulation of protein function by multisite phosphorylation-a 25 year update [ J ]. Trends Biochem Sci, 2000, 25(12) :596 -601.

二级参考文献15

  • 1Kornitzer D, Ciechanover A. Modes of regulation of ubiquitin-mediated protein degradation. J Cell Physiol, 2000, 182(1): 1 ~ 11
  • 2DeSalle L M, Pagano M. Regulation of the G1 to S transition by the ubiquitin pathway. FEBS Lett, 2001, 490(3): 179 ~ 189
  • 3Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.Cell, 1995, 82(6): 915~925
  • 4Carrano A C, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol, 1999, 1(4): 193 ~ 199
  • 5Lu L, Schulz H, Woff D A. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol, 2002, 3(1): 22 ~ 35
  • 6Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J,Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA, 2001, 98(9): 5043 ~ 5048
  • 7Yokoi S, Yasui K, Iizasa T, Takahashi T, Fujisawa T, Inazawa J.Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci, 2003, 94(4): 344 ~ 349
  • 8Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent ceils. Nat Cell Biol, 1999, 1(4): 207 ~ 214
  • 9Yang G, Ayala G, Marzo A D, Tian W, Frolov A, Wheeler T M, Thompson T C, Harper J W. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res, 2002, 8(11): 3419~ 3426
  • 10Roman-Gomez J, Castillejo J A, Jimenez A, Gonzalez M G, Moreno F,Rodriguez Mdel C, Barrios M, Maldonado J, Torres A. 5' CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia . Blood, 2002, 99(7): 2291 ~ 2296

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部